Literature DB >> 18492385

The treatment of distal femoral fractures in children using the LISS plate: a report of two cases.

Paul Baker1, Ian McMurtry, Andrew Port.   

Abstract

We report two cases in which the technique of fracture fixation using the Less Invasive Stabilisation System (LISS) has been successfully used in the management of distal femoral fractures in the child.

Entities:  

Mesh：

Year:  2008        PMID： 18492385      PMCID： PMC2647201          DOI： 10.1308/147870808X302985

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN： 0035-8843            Impact factor:   1.891


  4 in total

Review 1.  The development of the distal femur Less Invasive Stabilization System (LISS).

Authors:  R Frigg; A Appenzeller; R Christensen; A Frenk; S Gilbert; R Schavan
Journal:  Injury       Date:  2001-12       Impact factor: 2.586

Review 2.  Distal femoral fractures and LISS stabilization.

Authors:  P Schandelmaier; A Partenheimer; B Koenemann; O A Grün; C Krettek
Journal:  Injury       Date:  2001-12       Impact factor: 2.586

Review 3.  Femoral shaft fractures in children.

Authors:  James B Hunter
Journal:  Injury       Date:  2005-02       Impact factor: 2.586

4.  Treatment of distal femur fractures using the less invasive stabilization system: surgical experience and early clinical results in 103 fractures.

Authors:  Philip J Kregor; James A Stannard; Michael Zlowodzki; Peter A Cole
Journal:  J Orthop Trauma       Date:  2004-09       Impact factor: 2.512
  4 in total
  2 in total

1.  Elastic nailing for pediatric subtrochanteric and supracondylar femur fractures.

Authors:  Shital N Parikh; Senthil T Nathan; Michael J Priola; Emily A Eismann
Journal:  Clin Orthop Relat Res       Date:  2014-09       Impact factor: 4.176

2.  Closed reduction with crossed Kirschner wire fixation for displaced supracondylar femoral fractures in young children.

Authors:  Jin Li; Jiewen Ma; Xikai Guo; Changjie Yue; Kailei Chen; Jing Wang; Xin Tang
Journal:  Medicine (Baltimore)       Date:  2020-03       Impact factor: 1.817
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.